Global Next-Generation Sequencing (NGS) Services Market
17 Jul 2021
Healthcare & Pharmaceuticals
Impact Analysis on the Growth of Market
Activating Probable Propositions Amidst COVID-19 Crisis
With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More
NGS is the process of determining the precise order of nucleotides within a DNA molecule. It includes particular method or technology that is used to determine the order of the four bases—adenine, guanine, cytosine, and thymine—in a strand of DNA. It is currently being used to find and treat the genetic disorders prevalent in the population causing the market to grow simultaneously.
1. Market Drivers
1.1 Declining prices of technology of sequencing
1.2 High cost of sequencing infratructure
1.3 Availability of skilled people to handle sample preparation
1.4 NGS requires less throughput inputs
1.5 Advancements in sequencing technology
2. Market Restraints
2.1 Difficulty in establishing in-house throughput devices
1. Global Next-Generation Sequencing (NGS) Services Market, by Service Type:
1.1 Targeted Resequencing & Custom Gene Panels
1.3 De Novo Sequencing
1.4 Exome Sequencing
1.6 Whole-Genome Sequencing
1.8 Other Services
2. Global Next-Generation Sequencing (NGS) Services Market, by Application:
2.1.2 Infectious Diseases
2.1.3 Rare Genetic Disorders
2.1.4 Reproductive Health
2.1.5 Other Diagnostic Applications
2.2 Drug Discovery
2.3 Biomarker Discovery
2.4 Agriculture & Animal Research
2.5 Others Applications
3. Global Next-Generation Sequencing (NGS) Services Market, by Technology:
3.1 Sequencing By Synthesis
3.2 Ion Semiconductor Sequencing
3.3 Single-Molecule Real-Time Sequencing
3.4 Nanopore Sequencing
4. Global Next-Generation Sequencing (NGS) Services Market, by End User:
4.1 Academic & Government Institutes and Research Centers
4.2 Hospitals & Clinics
4.3 Pharmaceutical & Biotechnology Companies
4.4 Other End Users
5. Global Next-Generation Sequencing (NGS) Services Market, by Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa
The major players in the market are as follows:
2. Illumina, Inc.
3. Perkinelmer, Inc.
4. Eurofins Scientific SE
5. Gatc Biotech AG
6. Macrogen, Inc.
7. Qiagen N.V.
8. Genotypic Technology Pvt. Ltd.
9. Genewiz, Inc.
10. DNA Link, Inc.
11. Takara Bio Inc. (Part of Takara Holding Company Inc.)
12. Scigenom Labs Pvt. Ltd
13. Novogene Corporation
14. Personalis, Inc.
15. LGC Limited (A Part of KKR & Co. L.P.)
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH:
Research study on the Next-Generation Sequencing (NGS) Services Marketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the research methodology of verified market research and other aspects of the research study, kindly get in touch with our sales team.
The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:
- North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth Market Players Analys & Opportunity Outlook
- Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth Market Players Analysis & Opportunity Outlook
1.1 Overview of the Market
1.2 Scope of Report
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL NEXT-GENERATION SEQUENCING (NGS) SERVICES MARKETOUTLOOK
4.2 Market Dynamics
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL NEXT-GENERATION SEQUENCING (NGS) SERVICES MARKET, BY SERVICE TYPE
5.2 Targeted Resequencing& Custom Gene Panels
5.4 De Novo Sequencing
5.5 Exome Sequencing
5.7 Whole-Genome Sequencing
6 GLOBAL NEXT-GENERATION SEQUENCING (NGS) SERVICES MARKET, BY APPLICATION
6.2.2 Infectious Diseases
6.2.3 Rare Genetic Disorders
6.2.4 Reproductive Health
6.2.5 Other Diagnostic Applications
6.3 Drug Discovery
6.4 Biomarker Discovery
6.5 Agriculture & Animal Research
7 GLOBAL NEXT-GENERATION SEQUENCING (NGS) SERVICES MARKET, BY TECHNOLOGY
7.2 Sequencing By Synthesis
7.3 Ion Semiconductor Sequencing
7.4 Single-Molecule Real-Time Sequencing
7.5 Nanopore Sequencing
8 GLOBAL NEXT-GENERATION SEQUENCING (NGS) SERVICES MARKET, BY END USER
8.2 Academic & Government Institutes and Research Centers
8.3 Hospitals & Clinics
8.4 Pharmaceutical & Biotechnology Companies
9 GLOBAL NEXT-GENERATION SEQUENCING (NGS) SERVICES MARKET, BY GEOGRAPHY
9.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
9.3.4 Rest of Europe
9.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
9.4.4 Rest of Asia Pacific
9.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 – 2025
10 GLOBAL NEXT-GENERATION SEQUENCING (NGS) SERVICES MARKETCOMPETITIVE LANDSCAPE
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies
11 COMPANY PROFILES
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments
11.2 Illumina Inc.
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments
11.3 Perkinelmer, Inc.
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments
11.4 Eurofins Scientific SE
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments
11.5 Gatc Biotech AG
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments
11.6 Macrogen, Inc.
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments
11.7 Qiagen N.V.
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments
11.8 Genotypic Technology Pvt. Ltd.
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments
11.9 Genewiz, Inc.
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments
11.10 DNA Link, Inc.
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments
11.11 Takara Bio Inc.
11.11.2 Financial Performance
11.11.3 Product Outlook
11.11.4 Key Developments
11.12 Scigenom Labs Pvt. Ltd
11.12.2 Financial Performance
11.12.3 Product Outlook
11.12.4 Key Developments
11.13 Novogene Corporation
11.13.2 Financial Performance
11.13.3 Product Outlook
11.13.4 Key Developments
11.14 Personalis, Inc.
11.14.2 Financial Performance
11.14.3 Product Outlook
11.14.4 Key Developments
11.15 LGC Limited
11.15.2 Financial Performance
11.15.3 Product Outlook
11.15.4 Key Developments
12.1 Related Reports